Clinical trial
Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS
NCT00002940 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 1996
- Completion date
- March 31, 2002
- Enrollment
- Not reported
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.